(E)-2-(N-phenylbenzimidazol-2-yl)-3-(quinolin-3-yl)acylonitrile

ID: ALA4869185

PubChem CID: 164618501

Max Phase: Preclinical

Molecular Formula: C25H16N4

Molecular Weight: 372.43

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  N#C/C(=C\c1cnc2ccccc2c1)c1nc2ccccc2n1-c1ccccc1

Standard InChI:  InChI=1S/C25H16N4/c26-16-20(15-18-14-19-8-4-5-11-22(19)27-17-18)25-28-23-12-6-7-13-24(23)29(25)21-9-2-1-3-10-21/h1-15,17H/b20-15+

Standard InChI Key:  AEHJSOFLYGHWGV-HMMYKYKNSA-N

Molfile:  

 
     RDKit          2D

 29 33  0  0  0  0  0  0  0  0999 V2000
   38.1229  -17.1967    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.8367  -16.7873    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.8339  -15.9605    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.1211  -15.5511    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.4108  -16.7877    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.4120  -15.9671    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.6317  -15.7095    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   36.1465  -16.3735    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.6297  -17.0388    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   35.3252  -16.3723    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.9177  -15.6599    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.5033  -14.9454    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   34.9156  -17.0835    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.0943  -17.0824    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.6857  -16.3714    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.8667  -17.7964    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   33.6859  -17.7944    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.3760  -17.8198    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.4547  -17.0816    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.8659  -16.3738    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.4621  -15.6638    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.6432  -15.6605    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.2298  -16.3730    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.6400  -17.0800    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.5735  -17.9869    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.3156  -18.7670    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.8659  -19.3801    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.6732  -19.2080    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.9232  -18.4281    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  5  1  1  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  6  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9  5  1  0
  8 10  1  0
 10 11  1  0
 11 12  3  0
 10 13  2  0
 13 14  1  0
 14 15  2  0
 15 20  1  0
 19 16  1  0
 16 17  2  0
 17 14  1  0
  9 18  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 19  2  0
 18 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 18  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4869185

    ---

Associated Targets(Human)

TERT-RPE1 (415 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CAPAN-1 (772 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H460 (60772 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HL-60 (67320 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
K562 (73714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MM1.S (1111 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Z-138 (387 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 372.43Molecular Weight (Monoisotopic): 372.1375AlogP: 5.64#Rotatable Bonds: 3
Polar Surface Area: 54.50Molecular Species: NEUTRALHBA: 4HBD:
#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): #RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 4.10CX LogP: 5.73CX LogD: 5.73
Aromatic Rings: 5Heavy Atoms: 29QED Weighted: 0.39Np Likeness Score: -1.34

References

1. Perin N, Hok L, Beč A, Persoons L, Vanstreels E, Daelemans D, Vianello R, Hranjec M..  (2021)  N-substituted benzimidazole acrylonitriles as in vitro tubulin polymerization inhibitors: Synthesis, biological activity and computational analysis.,  211  [PMID:33248847] [10.1016/j.ejmech.2020.113003]

Source